NorthView Acquisition (NVACR) Competitors $0.20 +0.02 (+11.11%) As of 03:54 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsShort InterestTrendsBuy This Stock NVACR vs. DRTSW, ANZUW, ATAKW, BBLGW, BRSHW, BRSH, CTCXW, CRGT, GMVDW, and HSCSWShould you be buying NorthView Acquisition stock or one of its competitors? The main competitors of NorthView Acquisition include Alpha Tau Medical (DRTSW), Anzu Special Acquisition Corp I (ANZUW), Aurora Technology Acquisition (ATAKW), Bone Biologics (BBLGW), Bruush Oral Care (BRSHW), Bruush Oral Care (BRSH), Carmell (CTCXW), Cortigent (CRGT), G Medical Innovations (GMVDW), and Heart Test Laboratories (HSCSW). These companies are all part of the "medical equipment" industry. NorthView Acquisition vs. Its Competitors Alpha Tau Medical Anzu Special Acquisition Corp I Aurora Technology Acquisition Bone Biologics Bruush Oral Care Bruush Oral Care Carmell Cortigent G Medical Innovations Heart Test Laboratories NorthView Acquisition (NASDAQ:NVACR) and Alpha Tau Medical (NASDAQ:DRTSW) are both manufacturing companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, analyst recommendations, dividends, valuation, institutional ownership, profitability, community ranking and media sentiment. Which has preferable earnings & valuation, NVACR or DRTSW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNorthView AcquisitionN/AN/AN/AN/AN/AAlpha Tau MedicalN/AN/AN/AN/AN/A Does the media refer more to NVACR or DRTSW? In the previous week, Alpha Tau Medical had 1 more articles in the media than NorthView Acquisition. MarketBeat recorded 1 mentions for Alpha Tau Medical and 0 mentions for NorthView Acquisition. Alpha Tau Medical's average media sentiment score of 0.87 beat NorthView Acquisition's score of 0.00 indicating that Alpha Tau Medical is being referred to more favorably in the news media. Company Overall Sentiment NorthView Acquisition Neutral Alpha Tau Medical Positive Is NVACR or DRTSW more profitable? Company Net Margins Return on Equity Return on Assets NorthView AcquisitionN/A N/A N/A Alpha Tau Medical N/A N/A N/A Does the MarketBeat Community favor NVACR or DRTSW? NorthView Acquisition and Alpha Tau Medical both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformNorthView AcquisitionN/AN/AAlpha Tau MedicalN/AN/A SummaryAlpha Tau Medical beats NorthView Acquisition on 2 of the 2 factors compared between the two stocks. Get NorthView Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for NVACR and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NVACR vs. The Competition Export to ExcelMetricNorthView AcquisitionSurgical, Medical, And Dental Instruments And Supplies IndustryManufacturing SectorNASDAQ ExchangeMarket CapN/A$437.50K$2.22B$8.60BDividend YieldN/AN/A2.62%4.21%P/E RatioN/AN/A23.6419.18Price / SalesN/A0.0062.56113.15Price / CashN/AN/AN/A55.76Price / BookN/AN/A2.206.22Net IncomeN/AN/A-$452.02M$248.98M7 Day Performance11.11%-4.34%-0.85%-1.44%1 Month PerformanceN/A25.35%1.99%2.66%1 Year PerformanceN/A163.47%20.29%15.32% NorthView Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NVACRNorthView AcquisitionN/A$0.20+11.1%N/A+71.4%$0.00N/A0.002High Trading VolumeDRTSWAlpha Tau MedicalN/A$0.25+7.2%N/A-5.6%$0.00N/A0.0080News CoverageGap UpANZUWAnzu Special Acquisition Corp IN/A$0.05+20.2%N/A-32.9%$0.00N/A0.002Gap UpATAKWAurora Technology AcquisitionN/A$0.01+8.2%N/A+38.6%$0.00N/A0.00N/AGap UpBBLGWBone BiologicsN/A$13.50flatN/A-66.3%$0.00N/A0.002News CoverageBRSHWBruush Oral CareN/AN/AN/AN/A$0.00$2.92M0.0011BRSHBruush Oral CareN/A$0.00flatN/A-98.8%$0.00$2.92M0.0011CTCXWCarmellN/A$0.03+6.8%N/AN/A$0.00$32.84K0.0014Gap UpCRGTCortigentN/AN/AN/AN/A$0.00N/A0.006High Trading VolumeGMVDWG Medical InnovationsN/AN/AN/AN/A$0.00$4.42M0.0072HSCSWHeart Test LaboratoriesN/A$0.05+0.4%N/A+6.4%$0.00$14.70K0.0010Positive News Related Companies and Tools Related Companies DRTSW Alternatives ANZUW Alternatives ATAKW Alternatives BBLGW Alternatives BRSHW Alternatives BRSH Alternatives CTCXW Alternatives CRGT Alternatives GMVDW Alternatives HSCSW Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NVACR) was last updated on 6/18/2025 by MarketBeat.com Staff From Our PartnersWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredA new rule goes live in July — and the banks are quietly cashing inA major change is quietly going into effect this July — and Wall Street is already positioning for it. Big ...American Alternative | SponsoredTrump’s true trade war strategyThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredTrump Makes Major Crypto AnnouncementTrump's crypto revolution is now fully underway and now, we believe he’s about to deliver on his biggest promi...Crypto 101 Media | SponsoredMost Bitcoin holders have no idea this existsHere’s what 99% of Bitcoin holders don’t know: There’s a way to amplify your Bitcoin gains without buying m...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NorthView Acquisition Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share NorthView Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy NVACR Stock Free NVACR Stock Alerts